Cargando…

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats

Hepatopulmonary syndrome (HPS) is a lethal complication of cirrhosis characterized by hypoxia and overt intrapulmonary shunting. In this study, we investigated the effect of caffeine in rats with common bile duct ligation (CBDL)-induced liver cirrhosis and HPS. CBDL rats were randomly allocated to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ching-Chih, Chuang, Chiao-Lin, Tsai, Ming-Hung, Hsin, I.-Fang, Hsu, Shao-Jung, Huang, Hui-Chun, Lee, Fa-Yauh, Lee, Shou-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480428/ https://www.ncbi.nlm.nih.gov/pubmed/30925782 http://dx.doi.org/10.3390/ijms20071566

Ejemplares similares

Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats
por: Chang, Ching-Chih, et al.
Publicado: (2017)

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
por: Huang, Hui-Chun, et al.
Publicado: (2022)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats
por: Pun, Chon Kit, et al.
Publicado: (2021)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
por: Hsu, Shao-Jung, et al.
Publicado: (2020)

Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and G(α) Proteins Regulations in Cirrhotic Rats
por: Lee, Jing-Yi, et al.
Publicado: (2013)

NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats
por: Huang, Hui-Chun, et al.
Publicado: (2020)

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
por: Chang, Ting, et al.
Publicado: (2019)

Severe Hepatopulmonary Syndrome in an Adolescent Patient with Non-Cirrhotic Portal Fibrosis
por: Sood, Vikrant, et al.
Publicado: (2016)

Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis
por: Li, Tzu-Hao, et al.
Publicado: (2016)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

The Beneficial Effects of P2X(7) Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis
por: Tung, Hung-Chun, et al.
Publicado: (2015)

Ventilatory support and hospital stay after liver transplant in cirrhotic patients with hepatopulmonary syndrome
por: Pereira, José Leonardo Faustini, et al.
Publicado: (2017)

Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage
por: Lee, Fa-Yauh, et al.
Publicado: (2014)

The Diminished Expression of Proangiogenic Growth Factors and Their Receptors in Gastric Ulcers of Cirrhotic Patients
por: Luo, Jiing-Chyuan, et al.
Publicado: (2013)

Dehydroepiandrosterone sulfate and dehydroepiandrosterone sulfate/cortisol ratio in cirrhotic patients with septic shock: another sign of hepatoadrenal syndrome?
por: Tsai, Ming-Hung, et al.
Publicado: (2017)

THE HEPATOPULMONARY SYNDROME
por: NACIF, Lucas Souto, et al.
Publicado: (2014)

Hepatopulmonary syndrome
por: Raevens, Sarah, et al.
Publicado: (2022)

A 45-Year-Old Undiagnosed Cirrhotic Patient with Hepatopulmonary Syndrome as First Presentation: A Case Report
por: Dhoble, Chetan, et al.
Publicado: (2015)

Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization
por: Hung, Tsung-Hsing, et al.
Publicado: (2021)

Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Prognostic factors of cirrhotic patients with invasive fungal infections
por: Hung, Tsung-Hsing, et al.
Publicado: (2023)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Portal Bypass Complicated by Hepatopulmonary Syndrome
por: Monroe, Eric J., et al.
Publicado: (2021)

The association between clinical symptoms, laboratory findings and serum endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary syndrome
por: Khoshbaten, Manouchehr, et al.
Publicado: (2012)

Impact of Liver Transplantation on Carbon Monoxide Production as Measured by Arterial Carboxyhemoglobin Levels in Cirrhotic Patients with and without Hepatopulmonary Syndrome
por: Sabang, Ralph Llewel, et al.
Publicado: (2021)

Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury
por: Chiang, Chih-Hung, et al.
Publicado: (2011)

Corrigendum to “Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury”
por: Chiang, Chih-Hung, et al.
Publicado: (2022)

Hepatopulmonary syndrome: An update
por: Gandhi, Kejal D, et al.
Publicado: (2021)

Statin use in cirrhotic patients with infectious diseases: A population-based study
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018)

Nutrition Risk Assessment Using the Modified NUTRIC Score in Cirrhotic Patients with Acute Gastroesophageal Variceal Bleeding: Prevalence of High Nutrition Risk and its Independent Prognostic Value
por: Tsai, Ming-Hung, et al.
Publicado: (2019)

A case of hepatopulmonary syndrome
por: Offer, James, et al.
Publicado: (2015)

Pharmacological Treatment for Hepatopulmonary Syndrome
por: Eshraghian, Ahad, et al.
Publicado: (2013)

Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation
por: Hung, Tsung-Hsing, et al.
Publicado: (2022)

Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome
por: Li, X., et al.
Publicado: (2016)

Current concepts in the management of hepatopulmonary syndrome
por: Ho, Vincent
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lno05lvfue80t92vetnv91r94p